Markets · 1 sources covering this

Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investors

Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical company has set a Rs 938-988 price band, with proceeds from the fresh issue earmarked for debt repayment.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·55m ago
Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investors
Symbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical company has set a Rs 938-988 price band, with proceeds from the fresh issue earmarked for debt repayment.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/46d6528cd2475f22b51d88040d2d9fbf4dc211f7"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investors"></iframe>

Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investors

How 1 sources are covering this

Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investors

More from Markets

Crude oil prices head for second weekly gain as US steps up economic pressure on Iran

Gold could top Goldman’s $4,900 forecast as options demand fuels rally

India bond yields hit two-month high as rate hike fears intensify

FIIs near historical lows: Jio BlackRock flags potential contrarian setup for Indian equities

Reader

Trust & legal

Across the network